196 related articles for article (PubMed ID: 16033022)
1. Neuropathology in Alzheimer's disease: target of pharmacotherapy.
Souder E
J Am Acad Nurse Pract; 2005 Mar; Suppl():3-5. PubMed ID: 16033022
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
3. Current approaches in the treatment of Alzheimer's disease.
Shah RS; Lee HG; Xiongwei Z; Perry G; Smith MA; Castellani RJ
Biomed Pharmacother; 2008; 62(4):199-207. PubMed ID: 18407457
[TBL] [Abstract][Full Text] [Related]
4. Acetylcholinesterase inhibitors for Alzheimer's disease: anti-inflammatories in acetylcholine clothing!
Tabet N
Age Ageing; 2006 Jul; 35(4):336-8. PubMed ID: 16788077
[TBL] [Abstract][Full Text] [Related]
5. Amyloid inhibitors and Alzheimer's disease.
Xia W
Curr Opin Investig Drugs; 2003 Jan; 4(1):55-9. PubMed ID: 12625030
[TBL] [Abstract][Full Text] [Related]
6. Isoprenoids and Alzheimer's disease: a complex relationship.
Cole SL; Vassar R
Neurobiol Dis; 2006 May; 22(2):209-22. PubMed ID: 16406223
[TBL] [Abstract][Full Text] [Related]
7. Neuropathologic changes in Alzheimer's disease.
Wenk GL
J Clin Psychiatry; 2003; 64 Suppl 9():7-10. PubMed ID: 12934968
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of Alzheimer's disease].
Ishiura S; Hattori C
Tanpakushitsu Kakusan Koso; 2004 Nov; 49(14):2179-85. PubMed ID: 15559301
[No Abstract] [Full Text] [Related]
9. [Alzheimer's disease: from brain lesions to new drugs].
Forette F; Hauw JJ
Bull Acad Natl Med; 2008 Feb; 192(2):363-78; discussion 378-80. PubMed ID: 18819689
[TBL] [Abstract][Full Text] [Related]
10. Combination drug therapy for Alzheimer's disease: what is evidence-based, and what is not?
Xiong G; Doraiswamy PM
Geriatrics; 2005 Jun; 60(6):22-6. PubMed ID: 15948662
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease: seeking new ways to preserve brain function. Interview by Alice V. Luddington.
Davis KL
Geriatrics; 1999 Feb; 54(2):42-7; quiz 48. PubMed ID: 10024872
[TBL] [Abstract][Full Text] [Related]
12. [New therapeutic options in Alzheimer's disease].
García-Ruiz Espiga PJ; Echeverría A; García-Torres A; Contreras A
Rev Neurol; 2006 Apr 16-30; 42(8):478-81. PubMed ID: 16625510
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of Alzheimer's disease].
Bombois S; Lebert F; Vellas B; Pasquier F
Rev Prat; 2005 Nov; 55(17):1913-9. PubMed ID: 16396232
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic options in Alzheimer's disease.
Moreira PI; Zhu X; Nunomura A; Smith MA; Perry G
Expert Rev Neurother; 2006 Jun; 6(6):897-910. PubMed ID: 16784412
[TBL] [Abstract][Full Text] [Related]
15. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease.
Pákáski M; Kálmán J
Neurochem Int; 2008 Nov; 53(5):103-11. PubMed ID: 18602955
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of Alzheimer's disease].
López OL; Becker JT
Rev Neurol; 2002 Nov 1-15; 35(9):850-9. PubMed ID: 12436384
[TBL] [Abstract][Full Text] [Related]
17. Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
Wenk GL
J Clin Psychiatry; 2006; 67 Suppl 3():3-7; quiz 23. PubMed ID: 16649845
[TBL] [Abstract][Full Text] [Related]
18. Pathology and pathways of Alzheimer's disease with an update on new developments in treatment.
DeKosky ST
J Am Geriatr Soc; 2003 May; 51(5 Suppl Dementia):S314-20. PubMed ID: 12801388
[TBL] [Abstract][Full Text] [Related]
19. Future therapeutic approaches to Alzheimer's disease.
Davis KL
J Clin Psychiatry; 1998; 59 Suppl 11():14-6. PubMed ID: 9731545
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of statins in Alzheimer's disease.
Kandiah N; Feldman HH
J Neurol Sci; 2009 Aug; 283(1-2):230-4. PubMed ID: 19321181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]